罗哌卡因通过调控Nav1.8介导的巨噬细胞信号促进大鼠坐骨神经损伤后轴突再生
本研究在大鼠坐骨神经横断修复模型中,给予0.2%罗哌卡因或Nav1.8选择性抑制剂A-803467处理3天,发现罗哌卡因改善感觉、运动及感觉-运动协调功能,促进轴突再生和髓鞘碎片清除,并促进巨噬细胞从M1向M2表型转化,同时减弱Nav1.8上调。
要点
- 罗哌卡因连续神经阻滞可促进损伤坐骨神经的结构与功能恢复。
- 罗哌卡因加速髓鞘碎片清除并促进巨噬细胞M1向M2表型转化。
- 罗哌卡因减弱坐骨神经横断后Nav1.8的上调,可能为其促再生机制。
核心结论
- 罗哌卡因连续神经阻滞促进损伤坐骨神经的结构与功能恢复,可能通过调控Nav1.8介导的巨噬细胞信号实现。
研究设计与样本
- 在成年雌雄Sprague-Dawley大鼠中建立坐骨神经横断修复模型。
- 大鼠在损伤部位周围或骶部附近接受0.2%罗哌卡因或10 μM Nav1.8选择性抑制剂A-803467处理3天。
主要发现
- 与SNT加溶剂组相比,两个罗哌卡因组的感觉、运动及感觉-运动协调功能显著改善。
- 电生理振幅恢复指数:溶剂组0.43 ± 0.17 vs. 罗哌卡因组0.83 ± 0.25,n = 11,P < 0.001。
- NF-200阳性面积百分比:溶剂组19.88 ± 2.81 vs. 罗哌卡因组31.07 ± 2.62,n = 6,P < 0.001。
- 罗哌卡因组髓鞘碎片清除更快,巨噬细胞浸润增加并促进M1向M2表型转化。
- 坐骨神经横断后9天Nav1.8上调倍数:溶剂组4.12 ± 0.30 vs. 罗哌卡因组2.75 ± 0.36,n = 5,P < 0.001。
临床怎么用
- 提示罗哌卡因连续神经阻滞可能不仅提供镇痛,还可能促进周围神经损伤后的再生修复。
局限性
- 研究为大鼠坐骨神经横断修复模型,结论尚未在人体验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Continuous nerve block with ropivacaine is commonly performed after repair surgery for traumatic peripheral nerve injuries. After peripheral nerve injury, tetrodotoxin-resistant voltage-gated sodium channel Nav1.8 is upregulated and contributes to macrophage inflammation. This study investigated whether ropivacaine promotes peripheral nerve regeneration through Nav1.8-mediated macrophage signaling. METHODS: A sciatic nerve transection-repair (SNT) model was established in adult Sprague-Dawley rats of both sexes. The rats received 0.2% ropivacaine or 10 μM Nav1.8-selective inhibitor A-803467 around the injured site or near the sacrum for 3 days. Nerve regeneration was evaluated using behavioral, electrophysiologic, and morphological examinations. Moreover, myelin debris removal, macrophage phenotype, Nav1.8 expression, and neuropeptide expression were assessed using immunostaining, enzyme-linked immunosorbent assay, and Western blotting. RESULTS: Compared to the SNT-plus-vehicle group, the sensory, motor, and sensory-motor coordination functions of the two ropivacaine groups were significantly improved. Electrophysiologic (mean ± SD: recovery index of amplitude, vehicle 0.43 ± 0.17 vs. ropivacaine 0.83 ± 0.25, n = 11, P < 0.001) and histological analysis collectively indicated that ropivacaine significantly promoted axonal regrowth (percentage of neurofilament 200 [NF-200]-positive area: vehicle 19.88 ± 2.81 vs. ropivacaine 31.07 ± 2.62, n = 6, P < 0.001). The authors also found that, compared to the SNT-plus-vehicle group, the SNT-plus-ropivacaine group showed faster clearance of myelin debris, accompanied by significantly increased macrophage infiltration and transition from the M1 to M2 phenotype. Moreover, ropivacaine significantly attenuated Nav1.8 upregulation at 9 days after sciatic nerve transection (vehicle 4.12 ± 0.30-fold vs. ropivacaine 2.75 ± 0.36-fold, n = 5, P < 0.001), which coincided with the increased expression of chemokine ligand 2 and substance P. Similar changes were observed when using the selective Nav1.8 channel inhibitor A-803467. CONCLUSIONS: Continuous nerve block with ropivacaine promotes the structural and functional recovery of injured sciatic nerves, possibly by regulating Nav1.8-mediated macrophage signaling.
引用
- Cui Y, Wang X, Xu Y, et al. Ropivacaine Promotes Axon Regeneration by Regulating Nav1.8-mediated Macrophage Signaling after Sciatic Nerve Injury in Rats. Anesthesiology. 2023. PMID: 37669448. doi:10.1097/ALN.0000000000004761
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。